MICROEXON TARGETING FOR MODULATION OF RYR2 CHANNEL ACTIVITY

PHARMACEUTICAL COMPOSITION FOR TREATING SPINOCEREBELLAR ATAXIA

CORONAVIRUS IRNA COMPOSITIONS AND METHODS OF USE THEREOF

OLIGONUCLEOTIDE-MEDIATED KNOCKDOWN OF PLN

OLIGONUCLEOTIDE-MEDIATED KNOCKDOWN OF DUX4

OLIGONUCLEOTIDES

RNA-EDITING OLIGONUCLEOTIDES AND USES THEREOF

COMPOSITIONS AND METHODS FOR EMR2 MODIFICATION

APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHOD FOR USING GUIDE RNAS WITH CHEMICAL MODIFICATIONS

COMPOSITIONS AND METHODS FOR THE TARGETING OF LPA

METHODS FOR TREATING HEPATITIS B INFECTION

SMALL RNA-BASED PROGNOSTIC SIGNATURES AND THERAPEUTIC COMPOSITIONS FOR IDIOPATHIC PULMONARY FIBROSIS

COMPOSITIONS AND METHODS FOR PROGRAMMED DEATH LIGAND RECEPTOR (PD-L1) EXPRESSION

COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS

DOUBLE STRANDED RNAi AGENTS, COMPOSITIONS AND METHODS OF USE

ANTISENSE OLIGONUCLEOTIDES FOR TREATING A DISEASE OR CONDITION ASSOCIATED WITH AN ABNORMAL PROCESSING OF APP

GENE EDITING SYSTEMS AND USES THEREOF

PLIN1 RNAi INTERFERENCE AGENTS

RNAi Agent Targeting PCSK9 and Use Thereof

INTERFERING RNA FOR INHIBITING TOP1 GENE EXPRESSION AND USE THEREOF

RNAi Agents for Inhibiting Expression of Mucin 5AC (MUC5AC), Compositions Thereof, and Methods of Use

COMPOSITIONS AND METHODS FOR DELIVERING A MACROMOLECULE TO A CELL

POLYNUCLEOTIDES FOR SILENCING TRANSCRIPT VARIANT 1 OF ASSEMBLY FACTOR FOR SPINDLE MICROTUBULES AND APPLICATIONS THEREOF

RNAi Agents for Inhibiting Expression of Activin Receptor-Like Kinase 7 (ALK7), Compositions Thereof, and Methods of Use

Modulation of Apolipoprotein C-III (ApoCIII) Expression in Lipoprotein Lipase Deficient (LPLD) Populations

MODIFIED OLIGONUCLEOTIDES AND DOUBLE-STRANDED RNAS

ANTISENSE OLIGONUCLEOTIDES FOR TARGETING PROGRANULIN

Compounds and Methods for Modulating UBE3A-ATS

RNAi AGENTS FOR MODULATING SNCA

STABILIZED RNA AGENTS

RNA THERAPEUTICS FOR FIBRODYSPLASIA OSSIFICANS PROGRESSIVA AND USES THEREOF

CHEMICAL MODIFICATIONS OF SMALL INTERFERING RNA WITH MINIMAL FLUORINE CONTENT

DOUBLE-STRANDED RNAi AGENTS FOR TARGETING AND REGULATING HBV GENE EXPRESSION, AND A USE THEREOF

RUNX1 MODULATORS

ANTISENSE OLIGONUCLEOTIDE, COMPOSITIONS AND PHARMACEUTICAL FORMULATIONS THEREOF FOR EXON SKIPPING

COMPOSITIONS AND METHODS FOR TREATING PRIMARY CILIARY DYSKINESIA

Prime Editing Systems having pegRNA with Reduced Auto-inhibitory Interaction

Compounds and Methods for Reducing ATXN3 Expression

COMPOSITIONS AND METHODS TO MODULATE TUMOR MICROENVIRONMENT ASSOCIATED LONG NONCODING RNAS

THERAPEUTIC OLIGONUCLEOTIDES TO CORRECT CYSTIC FIBROSIS MUTATIONS

OLIGONUCLEOTIDES FOR MAPT MODULATION

Methods for Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Reduction

POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF

ANTI-FIBROTIC MICRORNA COMPOSITION

Antisense oligonucleotides for treatment of USHER 2A. Exon 68

siRNA COMPOSITIONS AND METHODS TARGETING ALPHA-SYNUCLEIN NUCLEIC ACIDS

COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROINFLAMMATORY DISEASES

INDUCTION OF STEM-LIKE ACTIVATED T CELLS

ANTI-C5 ANTIBODY/C5 IRNA DOSING REGIMENS FOR TREATING C5-ASSOCIATED DISEASES

RESPIRATORY SYNCYTIAL VIRUS (RSV) POLYANHYDRIDE NANOPARTICLE VACCINE

COMPOSITIONS AND METHODS FOR THE TREATMENT OF COMPLICATIONS AND DISORDERS RELATING TO VON WILLEBRAND FACTOR

METHODS FOR TREATMENT OF ANEMIA

PRODUCTS AND COMPOSITIONS

THERAPEUTIC AGENTS FOR METABOLISM-ASSOCIATED DISEASES

COMPOSITIONS FOR USE IN THE TREATMENT OF CHD2 HAPLOINSUFFICIENCY

SIRNA FOR TARGETED INHIBITION OF AGT GENE EXPRESSION AND USE THEREOF IN TREATING HYPERTENSION

POLYNUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

COMPOUNDS AND METHODS FOR MODULATING SMN2

RNAi Agents for Inhibiting Influenza A Viral Gene Expression, Compositions Thereof, and Methods of Use

Cyclic Antisense Therapeutics

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF LPA IN A CELL

DSRNA, USE THEREOF AND PREPARATION METHOD THEREFOR

SPLICE-SWITCHING OLIGONUCLEOTIDES TARGETING IL-4RA

COMPOSITIONS AND METHODS FOR INHIBITING LPA EXPRESSION

Oral Delivery of Antisense Conjugates Targeting PCSK9

OLIGONUCLEOTIDES FOR MODULATING REGULATORY T CELL MEDIATED IMMUNOSUPPRESSION

Genome Editing Compositions and Methods for Treatment of Friedreich's Ataxia

COMPOSITIONS AND METHODS FOR TREATING MENINGIOMA

METHODS AND COMPOSITIONS FOR MODULATING SPLICING AT ALTERNATIVE SPLICE SITES

MODIFIED MESSENGER RNA COMPRISING FUNCTIONAL RNA ELEMENTS

COMPOSITIONS AND METHODS FOR INHIBITING XDH EXPRESSION

REVERSIR MOLECULES AND METHODS OF USE THEREOF

SIRNA TARGETING ANGPTL4, AND CONJUGATES AND USES THEREOF

TREATMENT OF MST1 RELATED DISEASES AND DISORDERS

COMPOUNDS AND METHODS FOR TREATING HUMAN SUBJECTS

COMPOSITIONS AND METHODS FOR TREATING NONALCOHOLIC FATTY LIVER DISEASE

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

NONCODING RNA AGENTS (BCYRN1 AND DERIVATIVES THEREOF) TO TREAT DISEASES OF IMMUNITY

COMPOSITIONS AND METHODS FOR TREATING TRANSTHYRETIN (TTR) MEDIATED AMYLOIDOSIS

ANTISENSE OLIGONUCLEOTIDE-BASED ANTI-FIBROTIC THERAPEUTICS

COMPLEMENT COMPONENT C3 IRNA COMPOSITIONS AND METHODS OF USE THEREOF

REGULATION OF ACTIVITY OF RNAI MOLECULES

COMPOSITIONS AND METHODS OF USING PRKAG2-TARGETING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES

RNAi Agents for Inhibiting Expression of Thymic Stromal Lymphopoietin (TSLP), Compositions Thereof, and Methods of Use

Compositions and Methods for Hydroxyacid Oxidase 1 (HAO1) Gene Editing for Treating Primary Hyperoxaluria Type 1 (PH1)

RNAi Agents And Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3)

Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2C Using Exon Skipping

COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF INHIBIN SUBUNIT BETA E (INHBE) GENES

OLIGONUCLEOTIDES FOR PRNP MODULATION

Compositions and Methods for Lactate Dehydrogenase (LDHA) Gene Editing

COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION

HYBRID OLIGONUCLEOTIDES

AGENTS FOR MODULATING EXPRESSION

COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF INHIBIN SUBUNIT BETA E (INHBE) GENES

RNAi AGENTS OF PRION EXPRESSION

EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING CEBP/BETA

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Compositions and Methods for Modulating Complement Factor B Expression

Optimized RNAi Agents for Inhibiting Expression of Coronavirus (CoV) Viral Genomes, Compositions Thereof, and Methods of Use

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SIRNA AS ACTIVE INGREDIENT

METHODS AND COMPOSITIONS FOR SELECTIVELY MODULATING GENE EXPRESSION IN MEGAKARYOCYTES AND PLATELETS

DOUBLE STRANDED RNAi AGENTS, COMPOSITIONS AND METHODS OF USE

BRANCHED LIPID CONJUGATES OF siRNA FOR SPECIFIC TISSUE DELIVERY

FACTOR XII (HAGEMAN FACTOR) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), AND KININOGEN 1 (KNG1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS OF TREATING MUSCLE DYSTROPHY

RNAi Agents for Inhibiting Expression of Mitochondrial Amidoxime Reducing Component 1 (MARC1), Pharmaceutical Compositions Thereof, and Methods of Use

INHIBITORS OF EXPRESSION AND/OR FUNCTION

ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES

ANTI-C9ORF72 OLIGONUCLEOTIDES AND RELATED METHODS

COMPOUND FOR INHIBITING AGT GENE EXPRESSION, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

REVERSE TRANSCRIPTASE FOR NUCLEIC ACID SEQUENCING

COMPOSITIONS AND METHODS FOR TREATING PANCREATIC CANCER

SIRNA TARGETING AND REGULATING PCSK9 GENE EXPRESSION AND USE THEREOF

SIRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS

COMPOUNDS AND METHODS FOR REDUCING PRION EXPRESSION

OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION

COMPOSITIONS AND METHODS FOR TARGETING, EDITING, OR MODIFYING GENES

IMMUNE CELLS DEFECTIVE FOR SUV39H1

Methods and Compositions for Adar-Mediated Editing

ANTISENSE OLIGOMERS FOR TREATMENT OF NON-SENSE MEDIATED RNA DECAY BASED CONDITIONS AND DISEASES

NUCLEIC ACID COMPOUNDS

ASS1 Gene Insertion For The Treatment Of Citrullinemia Type I

DETECTION ASSAYS

SIRNA TARGETING RECQL1 HELICASE GENE

SMALL INTERFERING RNA TARGETING CFB AND USES THEREOF

NOVEL RNA THERAPEUTICS AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH PATHOGENIC FUS VARIANTS

RNA-EDITING OLIGONUCLEOTIDES AND USES THEREOF

MUSCLE-TARGETING COMPLEXES AND USES THEREOF

CRISPR INTERFERENCE THERAPEUTICS FOR C9ORF72 REPEAT EXPANSION DISEASE

COMPOSITIONS AND METHODS OF TREATING MUSCLE DYSTROPHY

OLIGONUCLEOTIDES HAVING 6-THIO-2'-DEOXYGUANOSINE RESIDUES AND USES THEREOF

RNAi Agents for Inhibiting Expression of Proprotein Convertase Subtilisin Kexin 9 (PCSK9), Pharmaceutical Compositions Thereof, and Methods of Use

Selective Antisense Compounds and Uses Thereof

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TRANSTHYRETIN

METHODS AND COMPOSITIONS FOR INHIBITION OF IRF4

NUCLEOTIDE ANALOGUES, AND PREPARATION AND APPLICATION THEREOF

MODIFIED ANTISENSE OLIGONUCLEOTIDES FOR TREATING HEPATITIS B VIRUS

Linkage Modified Oligomeric Compounds and Uses Thereof

COMPOSITIONS AND METHODS FOR CONTROL OF PSEUDOGYMNOASCUS DESTRUCTANS

NUCLEIC ACID COMPOUNDS

OLIGONUCLEOTIDES

TREATMENT OF MS4A4E RELATED DISEASES AND DISORDERS

Compositions and Methods for Treating FUS Associated Diseases

MUSCLE TARGETING COMPLEXES AND FORMULATIONS FOR TREATING MYOTONIC DYSTROPHY

COMPOSITIONS AND METHODS FOR NON-GENOTOXIC CONDITIONING

POLYNUCLEIC ACID MOLECULES TARGETING AGT AND USES THEREOF

ANTISENSE OLIGONUCLEOTIDES FOR TARGETING PROGRANULIN

METHODS OF TREATING X-LINKED GENETIC DISEASES

DUAL-ACTING siRNA BASED MODULATION OF C9orf72

MODIFIED ANTISENSE OLIGONUCLEOTIDES TARGETING FOXG1

PRIME EDITING OF SINGLE BASE MUTATIONS IN ALPHA-1 ANTITRYPSIN DEFICIENCY

COMPOSITIONS COMPRISING PLN-TARGETING ANTI-TRANSFERRIN RECEPTOR ANTIBODY-POLYNUCLEOTIDES AND METHODS OF USE THEREOF TO TREAT CARDIOMYOPATHY

METHODS AND COMPOSITIONS FOR MODULATING A GENOME

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD274/PD-L1 GENE

CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE

Linkage Modified Oligomeric Compounds and Uses Thereof

COMPOSITIONS AND METHODS FOR TREATMENT OF MICROSATELLITE DNA EXPANSION DISORDERS

ARTIFICIAL NUCLEIC ACID FOR INDUCING SPECIFIC THREE-DIMENSIONAL STRUCTURE

METHODS AND COMPOSITIONS FOR MODULATING A GENOME

COMPOUNDS AND METHODS FOR REDUCING PLN EXPRESSION

Method For Treating Cyclophilin B Associated Diseases

ANTISENSE OLIGONUCLEOTIDES

COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

RNAi Agents for Inhibiting Expression of Complement Component C3 (C3), Pharmaceutical Compositions Thereof, and Methods of Use

RNA-EDITING OLIGONUCLEOTIDES AND USES THEREOF

SIRNA MOLECULE AGAINST HUMAN TENASCIN-C (TNC) AND A PHARMACEUTICAL COMPOSITION COMPRISING IT

COMPOUNDS AND METHODS FOR REDUCING PCDH19 EXPRESSION

Method for Treating Cyclophilin D Associated Diseases

COMPOUNDS AND METHODS FOR REDUCING TAU EXPRESSION

MODIFIED HETERONUCLEIC ACID CONTAINING MORPHOLINO NUCLEIC ACID

METHODS AND COMPOSITIONS FOR MODULATING APOLIPOPROTEIN (A) EXPRESSION

Conjugated Antisense Compounds and Their Use

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

COMPOSITION FOR REGULATING SPLICING OF POLYBROMO 1 GENE COMPRISING SPLICING-SWITCH OLIGONUCLEOTIDE AS EFFECTIVE COMPONENT

POLYNUCLEIC ACID MOLECULES FOR INHIBITING EXPRESSION OF ANGPTL3, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 13 (HSD17B13) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

RNAi Agents for Inhibiting Expression of Complement Component C3 (C3), Pharmaceutical Compositions Thereof, and Methods of Use

Antisense oligonucleotides for the treatment of Stargardt disease

TREATMENT OF SOS2 RELATED DISEASES AND DISORDERS

SIRNA FOR INHIBITING ANGPTL3 GENE EXPRESSION AND USE THEREOF

COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

Targeting Skin-Related Conditions Using Bottlebrush Polymer-Conjugated Oligonucleotides

IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES

ANTISENSE MODULATION OF SETBP1 EXPRESSION

CHEMICALLY MODIFIED ANTISENSE OLIGONUCLEOTIDES (ASOS) AND COMPOSITIONS FOR RNA EDITING

OLIGONUCLEOTIDES FOR THE TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS ASSOCIATED WITH MSH3 ACTIVITY

COMPOSITIONS AND METHODS FOR INHIBITING COMPLEMENT FACTOR B

COMPOSITIONS AND METHODS FOR EDITING A TRANSTHYRETIN GENE

Compounds and Methods for Reducing KCNT1 Expression

RNAI CONSTRUCTS FOR INHIBITING PNPLA3 EXPRESSION AND METHODS OF USE THEREOF

COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION

COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B VIRUS (HBV) INFECTION AND HBV-ASSOCIATED DISEASES

MODULATION OF ABCB11 GENE TRANSCRIPTION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNAS

PRODUCTS AND COMPOSITIONS

INTERFERING RNA FOR INHIBITING PCSK9 GENE EXPRESSION AND USE THEREOF

METHODS FOR TREATING HYPERCHOLESTEROLEMIA

Compounds and Methods for Reducing LRRK2 Expression

TREATMENT OF MST1 RELATED DISEASES AND DISORDERS

MUCIN-5B (MUC5B) TARGETED SIRNA AND ANTISENSE OLIGONUCLEOTIDES AND METHODS OF USE THEREOF

CONJUGATES FOR TISSUE-SPECIFIC OLIGONUCLEOTIDE DELIVERY

RNAI CONSTRUCTS FOR INHIBITING SCAP EXPRESSION AND METHODS OF USE THEREOF

BASE EDITING OF TRANSTHYRETIN GENE

ENHANCING GENE TARGETING EFFICIENCY IN HUMAN CELLS WITH DNA-PK INHIBITOR TREATMENT

UBE3A ANTISENSE THERAPEUTICS

EDITING OLIGONUCLEOTIDE

SINGLE-STRANDED LOOP OLIGONUCLEOTIDES

RNAi Agents for Inhibiting Expression of Microtubule Associated Protein Tau (MAPT), Compositions Thereof, and Methods of Use

TRANSGENE CASSETTES DESIGNED TO EXPRESS A HUMAN MECP2 GENE

SYNTHETIC TRANSFER RNA WITH MODIFIED NUCLEOTIDES

COMPOSITIONS AND METHODS FOR INHIBITING CYTOCHROME P450 FAMILY 7 SUBFAMILY A MEMBER 1 (CYP7A1) EXPRESSION

OLIGONUCLEOTIDE-BASED DELIVERY VEHICLE FOR OLIGONUCLEOTIDES AGENTS AND METHODS OF USE THEREOF

SPLICE-SWITCHING OLIGONUCLEOTIDES

CERTAIN DUX4 INHIBITORS AND METHODS OF USE THEREOF

MUC5AC-TARGETED ANTISENSE OLIGONUCLEOTIDES AND RELATED METHODS FOR MODULATING MUCIN EXPRESSION

USE OF ANTISENSE OLIGONUCLEOTIDE IN PREPARATION OF DRUG FOR TREATING DISEASE CAUSED BY ABNORMAL THYROID

TARGETED TREATMENT OF SPLICEOPATHY-INDUCED NEUROLOGICAL DISORDERS

CHEMICALLY MODIFIED ANTISENSE OLIGONUCLEOTIDES (ASOS) AND COMPOSITIONS COMPRISING THE SAME FOR RNA EDITING

MODULATION OF SYNGAP1 GENE TRANSCRIPTION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNAS

IMPROVED OLIGONUCLEOTIDES TARGETING RNA BINDING PROTEIN SITES

COMPOSITIONS FOR THE SILENCING OF snoRNAS AND METHODS OF USING SAME

METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF LDHA

Oligonucleotide Terminal Phosphate Derivatives and Method of Use

MAPT ANTISENSE OLIGONUCLEOTIDE

Compositions for Treatment of Polycystic Kidney Disease

Compounds and Methods for Modulating UBE3A-ATS

ACTIN-BINDING LIM PROTEIN 3 (ABLIM3) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

ENHANCED HAMMERHEAD RIBOZYMES AND METHODS OF USE

MODIFIED DOUBLE STRANDED OLIGONUCLEOTIDES

FN3 DOMAIN-siRNA CONJUGATES AND USES THEREOF

GPC3 APTAMERS AND VARIANTS AND USE THEREOF

METHODS AND COMPOSITIONS FOR TREATING A PROPROTEIN CONVERTASE SUBTILISIN KEXIN (PCSK9) GENE-ASSOCIATED DISORDER

Allele-Specific Silencing of Transforming Growth Factor Beta Induced Gene with R124H Mutation Using Short Interfering RNA

SPLICE SWITCHING OLIGONUCLEOTIDES TARGETING PSEUDOEXONS

LPA inhibitors and uses thereof

Novel CRISPR gRNAs

MUSCLE-TARGETING COMPLEXES AND USES THEREOF

BIS-RNAI COMPOUNDS FOR CNS DELIVERY

ANTI-CANCER AGENTS

COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION

ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES

TARGETED INHIBITION OF REVERSE TRANSCRIPTION USING ANTISENSE OLIGOS

Cyclic Structured Oligonucleotides as Therapeutic Agents

MSI2 AS A THERAPEUTIC TARGET FOR THE TREATMENT OF MYOTONIC DYSTROPHY

COMPOSITIONS AND METHODS FOR TREATING TARDBP ASSOCIATED DISEASES

PHARMACEUTICAL COMBINATIONS FOR TREATMENT OF HBV

NUCLEIC ACID-POLYPEPTIDE NANO-PHARMACEUTICAL COMPOSTION FOR TREATING AND PREVENTING HUMAN PAPILLOMA VIRUS INFECTION

Linkage Modified Oligomeric Compounds

COMPOSITIONS AND METHODS FOR MODULATING APOC3 EXPRESSION

COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASES WITH siRNAS TARGETING TBX3

COMPOSITIONS AND METHODS OF MODULATING RNA AND PROTEIN INTERACTIONS

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS RELATING THERETO

OLIGONUCLEOTIDE INTERFERENCE TREATMENTS OF PROSTATE CANCER

MUSK-TARGETING OLIGONUCLEOTIDES

COMPOSITION AND METHOD FOR INHIBITING EXPRESSION OF PROTEIN LPA(APO(A))

Antisense oligonucleotides for treatment of USHER 2A. Exons 30-31

SIGNAL ACTIVATABLE NUCLEIC ACID COMPLEXES

METHODS AND COMPOSITIONS FOR TREATING ATHEROSCLEROSIS

SIRNA OR SALT THEREOF AND MEDICAMENT FOR INHIBITING EXPRESSION OF TMPRSS6 GENE, AND USE THEREOF

POLYNUCLEIC ACID MOLECULES FOR INHIBITING EXPRESSION OF FXI, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

XANTHINE DEHYDROGENASE (XDH) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

DOUBLE-STRANDED RNA MOLECULE FOR ADMINISTRATION TO THE EYE

TRANSLATION ENHANCING NUCLEIC ACID COMPOUNDS: ASO COUPLED TRANSLATION – UPREGULATION 1 (ACT-UP1) AND USES THEREOF

MODIFIED OLIGONUCLEOTIDES

COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND SAPONIN FOR THE TREATMENT OF MUSCLE-WASTING DISORDERS

SARM1 RNAi AGENTS

DOSING OF MUSCLE TARGETING COMPLEXES FOR TREATING MYOTONIC DYSTROPHY

COMPOUNDS FOR TREATMENT OF CONDITIONS AND DISEASES

PNPLA3-TARGETING SHORT INTERFERING RNA (SIRNA) MOLECULES AND USES THEREOF

UNIVERSAL NON-TARGETING SIRNA COMPOSITIONS AND METHODS OF USE THEREOF

Compounds and Methods for Reducing APOCIII Expression

COMPOSITIONS AND METHODS FOR INHIBITING STAG1 EXPRESSION AND USES THEREOF

Targeting Ligands For Therapeutic Compounds

Oligonucleotides

COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASES WITH SIRNAS TARGETING CIDEB

Nucleic acids for inhibiting expression of MASP-2 in a cell

COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASES WITH SIRNAS TARGETING GPAM

INSULIN RECEPTOR-BINDING APTAMER DIMER AND USE THEREOF

MODIFIED DOUBLE-STRANDED OLIGONUCLEOTIDE MOLECULE, MODIFIED DOUBLE-STRANDED OLIGONUCLEOTIDE CONJUGATE, AND USE THEREOF

SYF2 ANTISENSE OLIGONUCLEOTIDES

Selective Reduction of Allelic Variants

OLIGONUCLEOTIDES WITH 2'-DEOXY-2'-F-2'-C-METHYL NUCLEOTIDES

BRANCHED TRIPLE LIPID-MODIFIED NUCLEIC ACID COMPOUNDS

MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION

TARGETED CELL SELECTION AND RELEASE USING APTAMER COMPLEXES IN A CELL PROCESSING SYSTEM

MODIFIED RNAi AGENTS

RNAi Agents for Inhibiting Expression of Activin Receptor-Like Kinase 7 (ALK7), Compositions Thereof, and Methods of Use

RNAI CONSTRUCTS FOR INHIBITING PNPLA3 EXPRESSION AND METHODS OF USE THEREOF

Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis

LNCRNA TRANSCRIPTS IN MELANOMAGENESIS

COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF ALPHA-1 ANTITRYPSIN

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANGIOPOIETIN LIKE 7 (ANGPTL7) RELATED DISEASES

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF FOR EXON SKIPPING

SIRNA TARGETING ANGIOTENSINOGEN AND PHARMACEUTICAL USE OF SIRNA

EXPONENTIAL BASE-3 AND GREATER NUCLEIC ACID AMPLIFICATION WITH REDUCED AMPLIFICATION TIME

METHODS OF DESIGNING CONDITIONAL-ACTIVATABLE SMALL INTERFERING RNA SENSORS

siRNA SUPPRESSING EXPRESSION OF TRANSFERRIN RECEPTOR 2

CHEMICALLY MODIFIED OLIGONUCLEOTIDE HAVING RNAi ACTIVITY

COMPOUNDS AND METHODS FOR REDUCING IFNAR1 EXPRESSION